YakmoonYakdap (CEO Jeong-rae Cho), an AI-based medication management solution startup, has signed a Memorandum of Understanding (MOU) with the Seoul Metropolitan Pharmaceutical Association. This agreement follows a collaboration with the Gyeonggi Provincial Pharmaceutical Association in July. The Seoul-Gyeonggi region is a key region, accounting for half of the nation's approximately 25,000 pharmacies. Under the agreement, YakmoonYakdap has secured an official channel to provide its AI medication management service, "PhAI," to pharmacies in both regions.
PhAI is a medication management solution that leverages generative AI to comprehensively support prescription review, medication guidance data generation, and patient medication monitoring. Notably, it includes a multi-drug review function for elderly patients taking more than 10 medications simultaneously, reducing the average pharmacist's workload from over two hours to less than five minutes. AI performance is being verified and refined through joint research with the Clinical Pharmacy Laboratory at Seoul National University College of Pharmacy, and practicality has been enhanced through pharmacist participation.
Cho Jeong-rae, CEO of Yakmun Yakmdap, said, “When pharmacists’ field experience and technical skills are combined, solutions that provide real help to patients are completed,” and added, “We will do our best to ensure that PhAI can support pharmacists’ drug management work.”
Kim Wi-hak, President of the Seoul Metropolitan Pharmaceutical Association, said, “AI pharmaceutical services are a key driving force in providing integrated care services to local residents,” and added, “AI is not a replacement for pharmacists, but a tool to strengthen their expertise.”
Through this agreement, the Pharmaceutical Affairs Office and the Seoul and Gyeonggi Province Pharmaceutical Associations plan to jointly pursue projects such as ▲ introducing and improving an AI system to assist pharmacists in visiting drugstores and multi-drug consultations, ▲ developing pharmaceutical IT solutions necessary for an integrated care environment, and ▲ evaluating drug management cases and economic feasibility.
- See more related articles
You must be logged in to post a comment.